News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,962 Results
Type
Article (14505)
Company Profile (31)
Press Release (178426)
Section
Business (55499)
Career Advice (682)
Deals (9847)
Drug Delivery (29)
Drug Development (29531)
Employer Resources (71)
FDA (4986)
Job Trends (4319)
News (100660)
Policy (8508)
Tag
Academia (1320)
Alliances (16063)
Alzheimer's disease (424)
Approvals (4963)
Artificial intelligence (39)
Bankruptcy (78)
Best Places to Work (3503)
Breast cancer (37)
Cancer (290)
Cardiovascular disease (28)
Career advice (571)
Cell therapy (61)
Clinical research (24296)
Collaboration (109)
COVID-19 (1202)
Data (322)
Diabetes (50)
Diagnostics (1825)
Diversity, equity & inclusion (28)
Drug discovery (26)
Drug pricing (28)
Earnings (15209)
Employer resources (64)
Events (22783)
Executive appointments (90)
FDA (5114)
Funding (106)
Gene therapy (52)
GLP-1 (229)
Government (1346)
Healthcare (5779)
Infectious disease (1239)
Inflammatory bowel disease (42)
Interviews (110)
IPO (3688)
Job creations (919)
Job search strategy (511)
Layoffs (82)
Legal (1620)
Lung cancer (43)
Manufacturing (49)
Medical device (3497)
Medtech (3499)
Mergers & acquisitions (6197)
Metabolic disorders (121)
Neuroscience (515)
NextGen Class of 2024 (2172)
Non-profit (1858)
Northern California (291)
Obesity (65)
Opinion (47)
People (19592)
Phase I (5659)
Phase II (10472)
Phase III (9662)
Pipeline (96)
Policy (30)
Postmarket research (1164)
Preclinical (2161)
Press Release (48)
Radiopharmaceuticals (64)
Rare diseases (54)
Real estate (1674)
Regulatory (5944)
Research institute (1146)
Resumes & cover letters (90)
Southern California (280)
Startups (1359)
United States (3042)
Vaccines (260)
Weight loss (47)
Date
Today (62)
Last 7 days (258)
Last 30 days (857)
Last 365 days (9397)
2024 (8246)
2023 (10673)
2022 (14468)
2021 (16168)
2020 (15901)
2019 (14939)
2018 (11613)
2017 (10776)
2016 (10323)
2015 (12173)
2014 (8381)
2013 (6750)
2012 (7010)
2011 (7525)
2010 (6585)
Location
Africa (278)
Arizona (29)
Asia (13377)
Australia (2542)
California (676)
Canada (263)
China (73)
Colorado (33)
Connecticut (30)
Europe (34792)
Florida (86)
Georgia (60)
Illinois (93)
Indiana (51)
Japan (29)
Kansas (31)
Maryland (150)
Massachusetts (460)
Michigan (30)
Minnesota (90)
New Jersey (257)
New York (293)
North Carolina (158)
Northern California (291)
Pennsylvania (197)
South America (403)
Southern California (280)
Texas (85)
Washington State (121)
192,962 Results for "enigma biomedical group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging Biomarkers
Enigma Biomedical Group - USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of AbbVie’s next-generation F18 PET imaging biomarkers to assess the presence of four-repeat (4R) tau protein in patients with suspected neurodegenerative disease.
January 18, 2024
·
2 min read
Business
Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer
Enigma Biomedical USA announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer. Dr. Kolb’s passion for innovation and scientific rigor has driven his extensive career and broad recognition.
February 13, 2024
·
2 min read
Press Releases
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
October 31, 2024
·
8 min read
Press Releases
European Wellness Biomedical Group Unveils State-of-the-Art Premier Centre in Kota Kinabalu, Sabah
October 10, 2024
·
7 min read
Drug Development
Psyence Group’s NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
October 25, 2024
·
7 min read
Press Releases
Psyence Group’s NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
July 26, 2024
·
8 min read
Press Releases
Esaote Group expands production in India
November 6, 2024
·
2 min read
Deals
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has completed the sale of a 20% equity stake in Shanghai RAAS to Haier Group Corporation and forged a strategic alliance with Haier Group.
June 18, 2024
·
7 min read
Press Releases
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
October 9, 2024
·
1 min read
Press Releases
Pharming Group to participate in November 2024 investor conference
November 5, 2024
·
1 min read
1 of 19,297
Next
